We interview Vetter’s Thomas Otto about his career and the importance of sustainability in the pharma industry.

How did pharma fare during 2021 and will the industry move forward as the pandemic continues to impact lives on a global scale?

Gene therapy can help millions of patients with rare diseases, but one hurdle is preventing the field from achieving liftoff.

Changes are coming to Annex 1 of the EU’s GMP. What can pharma expect?

Building and managing an advanced therapy collection network is a significant challenge, but there is another route.

EsoCap CEO Isabelle Racamier tells the story behind a new drug delivery technology that could supplant syrups and pills for illnesses of the esophagus

We talk to a young excipient expert who won The Journal of Pharmaceutical Sciences’ 2021 Outstanding Early Career Scientists award.

A 2000-participant study in Europe has examined how drugs – and combinations of drugs – can affect the microbiota in our gut.

What can the Professor X of Heidelberg tell us about a new way of tackling cancer?

Antimicrobial resistance is an ongoing challenge for the pharmaceutical industry. What solutions can be created to address the problem?